- Home
- CCIX vs PACB Comparison
CCIX vs PACB Comparison
Compare CCIX & PACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCIX
- PACB
- Stock Information
- Founded
- CCIX 2023
- PACB 2000
- Country
- CCIX United States
- PACB United States
- Employees
- CCIX N/A
- PACB N/A
- Industry
- CCIX
- PACB Biotechnology: Laboratory Analytical Instruments
- Sector
- CCIX
- PACB Industrials
- Exchange
- CCIX Nasdaq
- PACB Nasdaq
- Market Cap
- CCIX 406.6M
- PACB 364.2M
- IPO Year
- CCIX 2024
- PACB 2010
- Fundamental
- Price
- CCIX $10.57
- PACB $1.27
- Analyst Decision
- CCIX
- PACB Buy
- Analyst Count
- CCIX 0
- PACB 8
- Target Price
- CCIX N/A
- PACB $2.13
- AVG Volume (30 Days)
- CCIX 391.7K
- PACB 10.4M
- Earning Date
- CCIX 01-01-0001
- PACB 08-06-2025
- Dividend Yield
- CCIX N/A
- PACB N/A
- EPS Growth
- CCIX N/A
- PACB N/A
- EPS
- CCIX 0.34
- PACB N/A
- Revenue
- CCIX N/A
- PACB $152,357,000.00
- Revenue This Year
- CCIX N/A
- PACB $3.33
- Revenue Next Year
- CCIX N/A
- PACB $18.52
- P/E Ratio
- CCIX $31.04
- PACB N/A
- Revenue Growth
- CCIX N/A
- PACB N/A
- 52 Week Low
- CCIX $10.00
- PACB $0.85
- 52 Week High
- CCIX $11.66
- PACB $2.72
- Technical
- Relative Strength Index (RSI)
- CCIX N/A
- PACB 59.90
- Support Level
- CCIX N/A
- PACB $1.25
- Resistance Level
- CCIX N/A
- PACB $1.40
- Average True Range (ATR)
- CCIX 0.00
- PACB 0.11
- MACD
- CCIX 0.00
- PACB 0.03
- Stochastic Oscillator
- CCIX 0.00
- PACB 73.95
About CCIX Churchill Capital Corp IX Ordinary Shares
Churchill Capital Corp IX is a blank check company.
About PACB Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.